Virtu Financial’s Acer Therapeutics Inc ACER Stock Holding History

Virtu Financial’s Portfolio ACER Stock Details ACER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-61,115	Closed	-$50K	–	2229
2023 Q3	$50K	Buy	+61,115	New	+$50.2K	0.01%	904
2023 Q1	–	Sell	-10,557	Closed	-$26K	–	2333
2022 Q4	$26K	Sell	10,557 -6,602	-38%	-$11.3K	﹤0.01%	1212
2022 Q3	$24K	Buy	17,159 +6,417	+60%	+$9.29K	﹤0.01%	1362
2022 Q2	$14K	Buy	+10,742	New	+$22.5K	﹤0.01%	1392
2021 Q2	–	Sell	-17,646	Closed	-$55K	–	2230
2021 Q1	$55K	Buy	+17,646	New	+$60K	﹤0.01%	1421
2019 Q3	–	Sell	-28,517	Closed	-$111K	–	1948
2019 Q2	$111K	Buy	+28,517	New	+$544K	0.01%	1124

Other funds holding ACER

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Virtu Financial's ACER Position: Q4 2023 in Review

Virtu Financial sold out of Acer Therapeutics Inc (ACER) in Q4 2023, closing a stake of 61,115 shares — an estimated $50K sold.

Virtu Financial first reported a position in ACER in Q2 2019 and held it in 6 quarters. The position peaked at $111K in Q2 2019. 2 funds tracked by Wall St. Rank hold ACER as of Q4 2023.

Virtu Financial reported no remaining Acer Therapeutics Inc position as of Q4 2023 after selling out during the quarter.
Virtu Financial sold 61,115 Acer Therapeutics Inc shares in Q4 2023, an estimated $50K.
Virtu Financial first reported a position in Acer Therapeutics Inc in Q2 2019 and held it in 6 quarters.
Virtu Financial's Acer Therapeutics Inc position peaked at $111K in Q2 2019.
2 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q4 2023.

Based on Virtu Financial's 13F filing for Q4 2023, filed 26 Feb 2024.